Healthcare

Mar. 9, 2026

Renota Wade Selected as Top Revenue Cycle Management Strategist of the Year by IAOTP

The International Association of Top Professionals (IAOTP) will honor Renota Wade at their annual awards gala at the Plaza Hotel in NYC

Mar. 3, 2026

Epic Pharma Faces Mixed Ruling in Gallstones Drug Case

Judge allows some claims to proceed, dismisses others as lacking detail.

Mar. 3, 2026

ROSEN Law Firm Encourages Inovio Pharmaceuticals Investors

Firm urges investors to join class action lawsuit against biotech company.

Mar. 2, 2026

Bragar Eagel & Squire Reminds Ardent Health Investors of Upcoming Deadline

Investors who suffered losses have until March 9th to contact the firm about their legal options.

Mar. 2, 2026

Rosen Law Firm Encourages Ultragenyx Investors to Secure Counsel Before Deadline

Investors who purchased Ultragenyx stock between August 2023 and December 2025 may be eligible for compensation.

Mar. 2, 2026

Hims Faces Regulatory Pressure and Expansion Challenges

Telehealth company's weight-loss drug business under scrutiny as it looks to diversify globally

Mar. 2, 2026

Rosen Law Firm Encourages Ardent Health Investors to Secure Counsel Before March 9 Deadline

Investors who purchased Ardent Health securities between July 2024 and November 2025 may be eligible for compensation.

Mar. 2, 2026

Royalty Pharma Appoints Kenneth Sun as Senior VP and Head of Asia

Expansion of Royalty Pharma's global platform to capitalize on growing biotech innovation in Asia

Mar. 1, 2026

New York Hospital Clears Site for $1B Campus Overhaul

SUNY Downstate Health Sciences University plans to build an ASC focused on cardiology and oncology procedures.

Feb. 28, 2026

NewYork-Presbyterian, nurses union reach tentative agreement, potentially ending strike

NYSNA and NewYork-Presbyterian reach a new deal after nurses overwhelmingly rejected an earlier proposal.

Feb. 27, 2026

Iovance Biotherapeutics Reports Strong Q4 Results, Highlights Pipeline Progress

Company sees accelerating demand for AMTAGVI cell therapy, extended cash runway, and upcoming milestones.

Feb. 27, 2026

Mesoblast Reports Strong H1 FY2026 Results, Driven by Ryoncil® Launch

Successful commercial launch of Ryoncil® generates $48.7 million in revenue, supporting investment in R&D and pipeline expansion

Feb. 27, 2026

Deadline Approaches for agilon health Investors

Kirby McInerney LLP Encourages Investors to Contact Firm

Feb. 25, 2026

Northwell Health Pension Plan Conversion Lawsuit Recommended for Dismissal

Magistrate judge says disclosures about 1999 plan changes provided sufficient notice under ERISA.

Feb. 24, 2026

Bayer Sues J&J Over Prostate Cancer Drug Claims

Bayer alleges false efficacy statements about Nubeqa versus Erleada in a New York federal lawsuit.

Feb. 24, 2026

Novotech Selects ObvioGo for Multi-Trial Digital Delivery

Partnership establishes standardized digital foundation to scale clinical trials globally

Feb. 24, 2026

Siemens Defeats Bid to Reinstate Medical Device Fraud Lawsuit

Appeals court affirms dismissal of False Claims Act suit alleging Siemens caused customers to bill federal programs for flawed devices

Feb. 24, 2026

Bayer Sues Johnson & Johnson Over Alleged Prostate Cancer Drug Misadvertising

Lawsuit alleges Johnson & Johnson made false claims about the efficacy of Bayer's cancer therapy NUBEQA®.

Feb. 23, 2026

Eli Lilly's Obesity Drug Zepbound Outperforms Novo Nordisk's Rival in Trial

Lilly's lead in the lucrative obesity drug market widens as its treatment shows greater weight loss than Novo's next-generation candidate.

Feb. 23, 2026

Natera Wins Court Battle Over Patented Cancer Testing Technology

Natera secures $19 million in damages and a permanent injunction against competitors Invitae and ArcherDX for infringing its cell-free DNA testing patents.